Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Conditions:   Fibrodyplasia Ossificans Progressiva (FOP);   Heterotopic Ossification (HO) Intervention:   Drug: garetosmab Sponsor:   Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials